Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 2269 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

 
Table of Contents
ERRATUM
Year : 2016  |  Volume : 20  |  Issue : 6  |  Page : 894

Erratum: Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives


Date of Web Publication24-Oct-2016

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2230-8210.192928

Rights and Permissions

How to cite this article:
. Erratum: Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives. Indian J Endocr Metab 2016;20:894

How to cite this URL:
. Erratum: Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives. Indian J Endocr Metab [serial online] 2016 [cited 2019 Nov 16];20:894. Available from: http://www.ijem.in/text.asp?2016/20/6/894/192928



In the article titled, “Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives” published in pages 22-31, issue 1, vol. 20 of Indian Journal of Endocrinology and Metabolism [1], the references 30 and 31 in the reference list are written incorrectly.

The correct references are following:

Reference 30: Rosenstock J, Jelaska A, Frappin G, Salsali A, Kim G, Woerle HJ, et al. Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. Diabetes Care 2014;37:1815-23.

Reference 31: Rosenstock J, Jelaska A, Zeller C, Kim G, Broedl UC, Woerle HJ; EMPA-REG BASALTM Trial Investigators. Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: A 78-week randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2015;17:936-48.

The references 30 and 31 cited in the article [Table 2] and [Table 3] should be renumbered accordingly.

 
   References Top

1.
John M, Gopinath D, Jagesh R. Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives. Indian J Endocr Metab 2016;20:22-31.  Back to cited text no. 1
[PUBMED]  Medknow Journal  




 

Top
 
  Search
 
    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
 References

 Article Access Statistics
    Viewed465    
    Printed2    
    Emailed0    
    PDF Downloaded95    
    Comments [Add]    

Recommend this journal